BenchSci
Best for biopharma R&D
Advanced AI research platform
Evidence-backed knowledge graph
Accelerates drug discovery
Enterprise-grade solution
Accelerate drug discovery with neurosymbolic AI that decodes disease biology.
Last updated: Apr 15, 2026
ENTERPRISE
benchsci.com
Quick Answer
BenchSci is a neurosymbolic AI platform for biopharma R&D that decodes disease biology to accelerate drug discovery. It leverages a Biological Evidence Knowledge Graph (BEKG) to integrate diverse scientific data, including proprietary internal data, and offers AI copilots for experimental design and hypothesis generation. Best for large pharmaceutical and biotech companies. Enterprise pricing available.
About BenchSci
BenchSci is a neurosymbolic AI platform for biopharma R&D that decodes disease biology to accelerate drug discovery. Its ASCEND platform leverages a Biological Evidence Knowledge Graph (BEKG) and advanced foundation models to provide AI copilots and co-scientists. It integrates diverse scientific data, including publications, multi-omics, and clinical trials, offering a unified view of diseases. Primarily for enterprise biopharma, pricing is custom.
What Makes It Unique
BenchSci's ASCEND platform is the first neuro-symbolic AI platform for biopharma, featuring a Biological Evidence Knowledge Graph (BEKG) that integrates licensed, public, and proprietary internal data. This unique approach, combined with human-in-the-loop curation and multimodal AI, ensures high data quality and mitigates AI hallucinations, enabling complex multi-hop scientific reasoning.
Use Cases & Target Users
Use Cases
Best For
Accelerating preclinical drug discovery
Unraveling complex disease biology
Guiding experimental design for biopharma R&D
Generating hypotheses in therapeutic areas
Improving experimental productivity for scientists
Company Size
SMALL
MEDIUM
ENTERPRISE
Fit Score
Complexity
ADVANCED
Target Team Size
SMALL_TEAM
LARGE_TEAM
Target Skill Level
EXPERT
Key Features
Neuro-symbolic AI platform for disease biology
Biological Evidence Knowledge Graph (BEKG) for data quality
AI copilots and co-scientists for accelerated discovery
Integrates diverse scientific data (publications, multi-omics, clinical trials)
Ingests client's proprietary internal data for customized insights
Multimodal AI extracts insights from text, figures, and supplementary files
Technical Specifications
API Available
SDK Available
MCP Compatible
Open Source
Team Features
SSO/Enterprise
Webhook Support
Has Demo
Deployment:
CLOUD
Compliance & Security
GDPR Compliant
Pros
- +Combines neuro-symbolic AI with a Biological Evidence Knowledge Graph (BEKG)
- +Integrates licensed, public, and proprietary internal scientific data for comprehensive insights
- +Leverages multimodal AI and human-in-the-loop curation for high data quality and reduced hallucinations
- +Provides AI copilots and co-scientists to accelerate discovery workflows
- +Deep domain expertise translates natural language queries into complex scientific reasoning
- +Proven track record of deployment and adoption across leading pharmaceutical companies
Limitations
- -Requires significant internal data ingestion for full customization
- -Primarily targets large biopharma, potentially less accessible for smaller research groups
- -Relies on enterprise-level deployment and dedicated support, not self-service
- -No explicit mention of a public API for external user integration
Powered By
Base Models
neuro-symbolic AI platformBiological Evidence Knowledge Graph (BEKG)
Decision Intelligence
Best For
Accelerating preclinical drug discovery
Unraveling complex disease biology
Guiding experimental design for biopharma R&D
Generating hypotheses in therapeutic areas
Improving experimental productivity for scientists
Not Ideal For
Individual academic researchers without institutional access
Small biotech startups with limited data
General scientific literature review outside of disease biology
Clinical trial management (focus is preclinical)
Frequently Asked Questions
Your Actions
Dimension Scores
Ease of Use6/10
Output Quality8/10
Value for Money7/10
Customization2/10
Support7/10
Integration8/10
Task Scores
Literature Search
9
Knowledge Synthesis
9
Data Extraction
8
Hypothesis Generation
8
Cross Reference
8
Paper Summarization
7
Methodology Guidance
7
Citation Management
5
Trust Score
70/100
Good
Based on 7 verified signals
Trust Signals
Verified CompanyBenchSci
Notable CustomersMerck, AbbVie, Daiichi-Sankyo +7
User Base10K-100K
Funding$218 million (US $170 million) as of May 25, 2023.
Team Size201-500
GDPR CompliantYes
Data ResidencyUS, Global
Switching & Migration
Migration Difficulty
Significant Effort
Dedicated scientific liaisons, Email, Knowledge Base
Quick Stats
Company & Links